ES2056822T3 - Agentes inmunoestimulantes. - Google Patents

Agentes inmunoestimulantes.

Info

Publication number
ES2056822T3
ES2056822T3 ES87305911T ES87305911T ES2056822T3 ES 2056822 T3 ES2056822 T3 ES 2056822T3 ES 87305911 T ES87305911 T ES 87305911T ES 87305911 T ES87305911 T ES 87305911T ES 2056822 T3 ES2056822 T3 ES 2056822T3
Authority
ES
Spain
Prior art keywords
immuno
stimulating agents
dideoxyzearalane
zearalene
zearalane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87305911T
Other languages
English (en)
Inventor
Martin J Jacobs
Iii Carl K Edwards
Paula Myers-Keith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
International Minerals and Chemical Corp
Original Assignee
International Minerals and Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by International Minerals and Chemical Corp filed Critical International Minerals and Chemical Corp
Application granted granted Critical
Publication of ES2056822T3 publication Critical patent/ES2056822T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)

Abstract

EL ACIDO RESORCICLICO DE LACTONA (RAL) Y SUS DERIVADOS ZEARALENONA, ZEARALENONA, ZEARALENE, ZEARALANES, ZEARALENOL, ZEARALANOL, DIDEOXIZEARALANE, Y SUS SALES FARMACEUTICAMENTE ACEPTABLES PUEDEN SER ADMINISTRADAS A VERTEBRADOS PARA ESTIMULAR DE UNA FORMA NO ESPECIFICA, AL SISTEMA INMUNOLOGICO.
ES87305911T 1986-07-03 1987-07-03 Agentes inmunoestimulantes. Expired - Lifetime ES2056822T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/881,926 US4842862A (en) 1986-07-03 1986-07-03 Immunostimulating agents

Publications (1)

Publication Number Publication Date
ES2056822T3 true ES2056822T3 (es) 1994-10-16

Family

ID=25379498

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87305911T Expired - Lifetime ES2056822T3 (es) 1986-07-03 1987-07-03 Agentes inmunoestimulantes.

Country Status (5)

Country Link
US (1) US4842862A (es)
EP (1) EP0251813B1 (es)
AT (1) ATE90872T1 (es)
DE (1) DE3786304T2 (es)
ES (1) ES2056822T3 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5110794A (en) * 1987-01-30 1992-05-05 Abbott Laboratories Method of immunization with partially cationized substances and said partially cationized substances
CA1337403C (en) * 1988-03-28 1995-10-24 Biomembrane Institute (The) Methods for the production of antibodies and induction of immune responses to tumor-associated gangliosides by immunization with ganglioside lactones
ATE153374T1 (de) * 1990-08-20 1997-06-15 Soma Genichiro Lps-produzierende bakterien, lipopolysiccharide und lps enthaltende arzneimittel und tierärztliche medikamente
US5622649A (en) * 1991-06-27 1997-04-22 Emory University Multiple emulsions and methods of preparation
WO1995022314A1 (en) * 1994-02-18 1995-08-24 Innovac Co. Inoculation of animals with dried, pelleted biological materials
US5795910A (en) * 1994-10-28 1998-08-18 Cor Therapeutics, Inc. Method and compositions for inhibiting protein kinases
CA2356622A1 (en) 1998-12-24 2000-07-06 Novation Pharmaceuticals Inc. Compounds which affect mrna stability and uses therefor
US6528489B1 (en) * 1999-09-23 2003-03-04 Ergon Pharmaceuticals Llc Mycotoxin derivatives as antimitotic agents
US6716448B2 (en) 2001-10-05 2004-04-06 Rubicon Scientific Llc Domesticated household pet food including maintenance amounts of ivermectin
EP1450860B1 (en) * 2001-10-05 2013-09-18 Rubicon Scientific LLC Animal feeds including actives
US7052712B2 (en) * 2001-10-05 2006-05-30 Rubicon Scientific Llc Animal feeds including actives and methods of preparing same
US6866862B2 (en) * 2001-10-05 2005-03-15 Rubicon Scientific Animal feeds including heartworm-prevention drugs
US20040091579A1 (en) * 2002-11-13 2004-05-13 Rubicon Scientific Llc; Extruded foodstuffs having maintenance level actives

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL131475C (es) * 1965-02-15
US3453367A (en) * 1966-06-29 1969-07-01 Commercial Solvents Corp Methods for treating inflammation with estrogenic compounds
GB1506563A (en) * 1974-04-25 1978-04-05 Williams J Immunosuppressive agents
US4173641A (en) * 1978-05-15 1979-11-06 Pfizer Inc. Di-O-n-alkyl glycerol derivatives as immune stimulants
JPS5513238A (en) * 1978-07-17 1980-01-30 Banyu Pharmaceut Co Ltd Novel compound having immunoactivating action, its preparation and application
US4281120A (en) * 1978-12-12 1981-07-28 Siegfried Herrling 7H-1,3,4-Thiadiazolo-[3,2-a]-pyrimidin-7-one-5-carboxylic compounds
US4239772A (en) * 1979-05-30 1980-12-16 International Minerals & Chemical Corp. Allyl and propyl zearalenone derivatives and their use as growth promoting agents
JPS56127369A (en) * 1980-02-15 1981-10-06 Mitsui Toatsu Chem Inc Nevel piperazine compound, its preparation and utilization
US4442031A (en) * 1981-10-15 1984-04-10 Hoffmann-La Roche Inc. Immunopotentiating peptides
FR2515188A1 (fr) * 1981-10-27 1983-04-29 Roussel Uclaf Nouveaux derives du 3-amino-pregn-5-ene, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant
JPS5998015A (ja) * 1982-11-27 1984-06-06 Microbial Chem Res Found 免疫賦活剤
US4681760A (en) * 1985-04-17 1987-07-21 The Board Of Trustees Of The Leland Stanford Junior University Method of conferring immunotolerance to a specific antigen

Also Published As

Publication number Publication date
DE3786304T2 (de) 1993-10-21
EP0251813B1 (en) 1993-06-23
DE3786304D1 (de) 1993-07-29
US4842862A (en) 1989-06-27
ATE90872T1 (de) 1993-07-15
EP0251813A2 (en) 1988-01-07
EP0251813A3 (en) 1990-01-31

Similar Documents

Publication Publication Date Title
NO883591D0 (no) Dermal administreringsform.
IT8622683A0 (it) Dispositivo terapeutico per la somministrazione di medicamenti.
IT8748270A0 (it) Sistema terapeutico con azione sistemica applicabile per via orale
DZ1077A1 (fr) Nouvelles préparation pharmaceutique pour administration orale.
ATE72991T1 (de) Nasale verabreichung von arzneimitteln.
FI885329A0 (fi) Nya fluorcytidinderivat.
DE68913194T2 (de) Therapeutische chinuclidinderivate.
IT1219811B (it) Derivati peptidici,loro preparazione e loro impiego come medicamenti
MX9203328A (es) Complejo de interferon de zinc-protamina-alfa.
ES2056822T3 (es) Agentes inmunoestimulantes.
DE3872937T2 (de) Benzoylaminophenoxybuttersaeure-derivate.
DE68913137D1 (de) Carbonsäure-Derivate.
FI870200A0 (fi) 7-(azabicykloalkyl) -kinolonkarboksylsyra- och nafthyridonkarboksylsyraderivat.
DE3780257D1 (de) Passives arzneimittelverabreichungssystem.
DE3868866D1 (de) Ergolinderivate mit antiparkinsonwirkung.
NO892764L (no) Medikamentell administreringsform for droevtyggere.
DE3861529D1 (de) Arzneizubereitung mit indomethacin.
DE3873167D1 (de) Thiazolidin-4-on-derivate und deren saeure-additionssalze.
IT8722501A0 (it) Formulazioni farmaceutiche per somministrazione transdermica.
DK382788A (da) 4-amino-substituerede 1,2-dihydroxy-naphthalen-derivater
NO893303L (no) Emulsjon for parenteral administrering.
NO920355L (no) 2,5-diaryl-1,3,4-oksadiazolhydroksyester, -hydroksysyrer og -acetoksysyrer
ES2019634B3 (es) Terapia con clorfeniramina.
DE68921180T2 (de) Apparat für die Verabreichung von Medikamenten für die Veterinärmedizin.
IT8722647A0 (it) Composizione farmaceutica per somministrazione nasale.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 251813

Country of ref document: ES